Stamford, CT -- (SBWIRE) -- 09/18/2013 -- High Rising Stocks provides investors with the hottest penny stock alerts on a regular basis. Our Penny Stock Newsletter will send you alerts through our Free E Newsletters with High Yielding alerts, market forecasting, stock tips and strategies, and offer you the tools to help you along the way with the goal of keeping you loyal to our service. Today’s stocks to watch are: Arch Coal Inc (NYSE:ACI), Molycorp Inc. (NYSE:MCP), Repros Therapeutics Inc (NASDAQ:RPRX), Amarin Corporation plc (ADR) (NASDAQ:AMRN)
Arch Coal Inc (NYSE:ACI) slipped 0.84% to $4.73 on a traded volume of 1.17 million shares. The company published its fourth corporate social responsibility report, which covers the 2011 and 2012 calendar years. The report outlines how Arch is delivering energy and resources to meet the world's growing demand in a responsible manner.
Should Investors Buy ACI After Yesterday’s Slump? Find Out Here
Molycorp Inc. (NYSE:MCP) is down 0.15% to $6.71 on a traded volume of 1.02 million shares. So far this year, the stock is down over 26%. The 52-week range for the stock is $4.70 and $14.44. Molycorp, Inc. provides Rare Earths and Molybdenum products to companies.
Can Traders Buy MCP After The Solid Rally? Get Free Trend Analysis Here
Repros Therapeutics Inc (NASDAQ:RPRX) moved up 9.30% to $26.10 on a traded volume of 1.86 million shares. Previous day, Repros Therapeutics Inc. reported topline results from both the second pivotal efficacy study as well as the 6 month safety study of Androxal in the treatment of men with secondary hypogonadism. Secondary hypogonadism is the largest subset of hypogonadal men accounting for greater than 85% of the reported cases.
Should Investors Buy RPRX After Yesterday’s Slump? Find Out Here
Amarin Corporation plc (ADR) (NASDAQ:AMRN) went down 0.46% to $6.41 on a traded volume of 969k shares. Amarin Corporation plc announced that John F. Thero, Amarin's President, is scheduled to present a general company update at the 2013 Aegis Capital Healthcare Conference in Las Vegas, NV on September 26, 2013, at 4:30 p.m. ET.
Goldman started coverage on Amarin with a neutral rating. The price target set at $6.80.
How Should Investors Trade AMRN After The Recent Volatility? Get Free Trend Analysis Here
High Rising Stocks is always searching the market every day for massive penny stock runs before they happen so you don't have to.We will send you alerts through our Free E Newsletters with High Yielding alerts, market forecasting, stock tips and strategies, and offer you the tools to help you along the way with the goal of keeping you loyal to our service.
Carriage Consulting Group, High Rising Stocks, their Members, officers, directors, employees, affiliates, or any other related person(s) (collectively, “High Rising Stocks”) are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. High Rising Stocks as defined are neither licensed nor qualified to provide investment advice and you are specifically and adamantly advised not to rely upon anything said/posted/communicated/implied or expressed by High Rising Stocks as defined.
Read full Disclaimer at: http://highrisingstocks.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)